Skip to main content

Effect of Platelet-Activating Factor Antagonist on Brain Injury in Rats

  • Conference paper
Brain Edema IX

Part of the book series: Acta Neurochirurgica ((NEUROCHIRURGICA,volume 60))

  • 195 Accesses

Summary

The ability of a platelet-activating factor (PAF) antagonist to reduce infarct size has been reported in a animal model of focal brain ischemia. The authors studied the effect of PAF antagonist (TCV-309) on cold brain injury in rats. Twenty–four hours after injury, water content was determined by both dry ing-weighing and spesific gravimetric techniques, and ischemic brain damage was assesed with 2,3,5-triphenyltetrazolium chloride in multiple coronal sections. Pretreatment with TCV-309 (lmg/kg) significantly reduced the water content (p < 0.01) and volume of ischemic damage (p < 0.001) produced by the cold brain injury. These results indicate that PAF antagonist can ameliorate secondary brain tissue damage following brain injury.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304–1308

    Article  PubMed  CAS  Google Scholar 

  2. Braquet P, Touqui L, Shen TY, Vargaftic BB (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39: 9–145

    Google Scholar 

  3. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanvio F, D’urso N, Marchisio PC (1987) Human endothelial cells are target for platelet-activating factor. 1. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 139: 2439–2446

    PubMed  CAS  Google Scholar 

  4. Dietrich WD, Busto R, Ginsberg MD (1984) Cerebral endothelial microvilli: formation following global forebrain ischemia. J Neuropathol Exp Neurol 43: 72–83

    Article  PubMed  CAS  Google Scholar 

  5. Elliot KAC, Jasper H (1949) Measurement of experimentally induced brain swelling and shrinkage. Am J Physiol 157: 122–129

    Google Scholar 

  6. Germano IM, Bartkowski HM, Cassel ME, Pitts LH (1987) The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. J Neurosurg 67: 81–87

    Article  PubMed  CAS  Google Scholar 

  7. Kochaneh PM, Dutka AJ, Kumaroo KK, Hallenbeck JM (1987) Platelet activating factor receptor blockade enhances recovery after multifocal brain ischemia. Life Sci 41: 2639–2644

    Article  Google Scholar 

  8. Kochanek PM, Nemoto EM, Melick JA, Evans RW, Burke DF (1988) Cerbrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. J Cereb Blood Flow Metab 8: 546–551

    Article  PubMed  CAS  Google Scholar 

  9. Marmarou A, Poll W, Shulman K, Bhagavan H (1978) A simple gravimetric technique for measurement of cerebral edema. J Neurosurg 49: 530–537

    Article  PubMed  CAS  Google Scholar 

  10. Maxwell W, Irvine A, Watt C, Graham DI, Adams JH, Gennarelli TA (1991) The microvascular response to stretch injury in the adult guinea pig visual system. J Neurotrauma 8: 271–279

    Article  PubMed  CAS  Google Scholar 

  11. Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG (1987) Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphospho-inositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Bio-phys Res Commun 149: 580–587

    Article  CAS  Google Scholar 

  12. Spinnewyn B, Blavet N, Clostre F, Bazen N, Braquet P (1987) Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins 34: 337–349

    Article  PubMed  CAS  Google Scholar 

  13. Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, Nishikawa K (1992) Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J Pharmacol Exp Ther 260: 748–755

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag

About this paper

Cite this paper

Tokutomi, T., Sigemori, M., Kikuchi, T., Hirohata, M. (1994). Effect of Platelet-Activating Factor Antagonist on Brain Injury in Rats. In: Ito, U., et al. Brain Edema IX. Acta Neurochirurgica, vol 60. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9334-1_139

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-9334-1_139

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-9336-5

  • Online ISBN: 978-3-7091-9334-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics